USFDA issues 2 observations for Piramal Pharma Bethlehem Facility - Video
|
Overview
Piramal Pharma has announced that the US Food and Drug Administration (USFDA) has concluded a Good Manufacturing Practices (GMP) Inspection with two observations at the Company's Bethlehem facility.
The inspection was held from 18th September 2023 to 27th September 2023.
"On conclusion of the inspection, a Form-483 was issued with 2 observations," the Company informed in a BSE filing.
For more details, check out the link given below:
Piramal Pharma Gets 2 USFDA Observations For Bethlehem Facility
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
